1. Home
  2. LCII vs ACAD Comparison

LCII vs ACAD Comparison

Compare LCII & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCI Industries

LCII

LCI Industries

HOLD

Current Price

$121.06

Market Cap

2.3B

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$27.04

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCII
ACAD
Founded
1956
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
4.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
LCII
ACAD
Price
$121.06
$27.04
Analyst Decision
Hold
Buy
Analyst Count
5
22
Target Price
$102.40
$29.05
AVG Volume (30 Days)
281.6K
1.4M
Earning Date
10-30-2025
11-05-2025
Dividend Yield
3.78%
N/A
EPS Growth
38.80
98.53
EPS
7.12
1.54
Revenue
$3,992,455,000.00
$1,047,118,000.00
Revenue This Year
$10.55
$15.16
Revenue Next Year
$4.21
$11.42
P/E Ratio
$17.09
$17.62
Revenue Growth
5.74
12.69
52 Week Low
$72.31
$13.40
52 Week High
$122.53
$27.73

Technical Indicators

Market Signals
Indicator
LCII
ACAD
Relative Strength Index (RSI) 70.92 69.78
Support Level $112.55 $26.38
Resistance Level $118.26 $27.73
Average True Range (ATR) 3.09 0.83
MACD 0.27 0.14
Stochastic Oscillator 86.86 88.00

Price Performance

Historical Comparison
LCII
ACAD

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: